ホーム>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Sucralfate

Sucralfate

カタログ番号GC44964

スクラルファート (スクロース オクタサルフェート - アルミニウム複合体) は、強力で経口的に活性な胃保護剤であり、全身への影響はありません。

Products are for research use only. Not for human use. We do not sell to patients.

Sucralfate 化学構造

Cas No.: 54182-58-0

サイズ 価格 在庫数 個数
500mg
$43.00
在庫あり
1g
$82.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Sucralfate is a cytoprotective agent which has been employed for prevention and treatment of several gastrointestinal diseases.

Sucralfate is a cytoprotective agent which has been employed for prevention and treatment of several gastrointestinal diseases. Enemas containing Sucralfate improves the inflammation and increases the tissue contents of neutral and acid mucins. The content of neutral mucins does not change with the time or concentration of Sucralfate used, while acid mucins increases with concentration and time of intervention. A significant increase in tissue content of neutral mucins in animals subjected to irrigation with Sucralfate (SCF) is found compare to animals irrigated with S.F. 0.9%, regardless of the concentration and duration of intervention[1].

References:
[1]. Chaim FM, et al. Evaluation of the application of enemas containing sucralfate in tissue content of neutral and acid mucins in experimental model of diversion colitis. Acta Cir Bras. 2014 Sep;29(9):544-52.

レビュー

Review for Sucralfate

Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sucralfate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.